Estimating Centre for Disease Control and Prevention-defined overdose risk in people prescribed opioids for chronic non-cancer pain: implications for take-home naloxone provision.
作者信息
Lintzeris Nicholas, Santo Thomas, Nielsen Suzanne, Degenhardt Louisa, Campbell Gabrielle
机构信息
Drug and Alcohol Services, South Eastern Sydney Local Health District, Sydney, New South Wales, Australia.
Division Addiction Medicine, University of Sydney, Sydney, New South Wales, Australia.
出版信息
Intern Med J. 2019 Aug;49(8):1054-1055. doi: 10.1111/imj.14386.
Abstract
摘要
相似文献
1
Estimating Centre for Disease Control and Prevention-defined overdose risk in people prescribed opioids for chronic non-cancer pain: implications for take-home naloxone provision.评估疾病控制与预防中心定义的慢性非癌性疼痛患者服用阿片类药物的过量风险：对提供纳洛酮带回家的影响。
Intern Med J. 2019 Aug;49(8):1054-1055. doi: 10.1111/imj.14386.
2
Knowledge of Opioid Overdose and Attitudes to Supply of Take-Home Naloxone Among People with Chronic Noncancer Pain Prescribed Opioids.慢性非癌症疼痛患者对阿片类药物处方知识、阿片类药物过量及携带纳洛酮的态度。
Pain Med. 2018 Mar 1;19(3):533-540. doi: 10.1093/pm/pnx021.
3
Distribution of naloxone for overdose prevention to chronic pain patients.为预防药物过量向慢性疼痛患者分发纳洛酮。
Prev Med. 2015 Nov;80:41-3. doi: 10.1016/j.ypmed.2015.05.016. Epub 2015 May 27.
4
Findings and lessons learnt from implementing Australia's first health service based take-home naloxone program.从澳大利亚首个基于上门纳洛酮的卫生服务计划实施中得到的发现和经验教训。
Drug Alcohol Rev. 2018 May;37(4):464-471. doi: 10.1111/dar.12400. Epub 2016 Apr 13.
5
Co-prescription of naloxone as a Universal Precautions model for patients on chronic opioid therapy-Observational study.纳洛酮联合处方作为慢性阿片类药物治疗患者的通用预防模型——观察性研究。
Subst Abus. 2016 Oct-Dec;37(4):591-596. doi: 10.1080/08897077.2016.1179704. Epub 2016 Apr 19.
6
Patient, family members and community pharmacists' views of a proposed overdose prevention intervention delivered in community pharmacies for patients prescribed high-strength opioids for chronic non-cancer pain: An explorative intervention development study.患者、家庭成员及社区药剂师对一项拟在社区药房为开具高强度阿片类药物用于慢性非癌性疼痛的患者实施的过量用药预防干预措施的看法：一项探索性干预措施开发研究。
Drug Alcohol Rev. 2023 Mar;42(3):517-526. doi: 10.1111/dar.13554. Epub 2022 Sep 27.
7
Racial inequities in U.S. naloxone prescriptions.美国纳洛酮处方中的种族不平等现象。
Subst Abus. 2020;41(2):232-244. doi: 10.1080/08897077.2019.1686721. Epub 2019 Nov 13.
8
Nonrandomized Intervention Study of Naloxone Coprescription for Primary Care Patients Receiving Long-Term Opioid Therapy for Pain.纳洛酮联合处方用于接受长期阿片类药物治疗疼痛的初级保健患者的非随机干预研究
Ann Intern Med. 2016 Aug 16;165(4):245-52. doi: 10.7326/M15-2771. Epub 2016 Jun 28.
9
Attitudes Toward Naloxone Prescribing in Clinical Settings: A Qualitative Study of Patients Prescribed High Dose Opioids for Chronic Non-Cancer Pain.临床环境中对纳洛酮处方的态度：一项针对因慢性非癌性疼痛而开具高剂量阿片类药物的患者的定性研究。
J Gen Intern Med. 2017 Mar;32(3):277-283. doi: 10.1007/s11606-016-3895-8. Epub 2016 Oct 31.
10
Prevention of Opioid Overdose.预防阿片类药物过量。
N Engl J Med. 2019 Jun 6;380(23):2246-2255. doi: 10.1056/NEJMra1807054.
引用本文的文献
1
An evidence-based digital prescription opioid safety toolkit for national dissemination: co-design and user testing.用于全国推广的基于证据的数字处方阿片类药物安全工具包：联合设计与用户测试
Front Digit Health. 2025 Jul 11;7:1600836. doi: 10.3389/fdgth.2025.1600836. eCollection 2025.
2
Opioid-related policy changes: Experiences and perspectives from people who use opioids to manage non-cancer chronic pain.阿片类药物相关政策变化：使用阿片类药物治疗非癌症慢性疼痛人群的经验和观点。
Drug Alcohol Rev. 2023 Sep;42(6):1482-1492. doi: 10.1111/dar.13683. Epub 2023 May 30.
3
A new side-effect of sufentanil: increased monocyte-endothelial adhesion.舒芬太尼的一个新副作用：单核细胞-内皮细胞黏附增加。
BMC Anesthesiol. 2021 Nov 3;21(1):267. doi: 10.1186/s12871-021-01487-3.
本文引用的文献
1
An overview of take-home naloxone programs in Australia.澳大利亚带离型纳洛酮项目概述。
Drug Alcohol Rev. 2018 May;37(4):440-449. doi: 10.1111/dar.12812.
2
Knowledge of Opioid Overdose and Attitudes to Supply of Take-Home Naloxone Among People with Chronic Noncancer Pain Prescribed Opioids.慢性非癌症疼痛患者对阿片类药物处方知识、阿片类药物过量及携带纳洛酮的态度。
Pain Med. 2018 Mar 1;19(3):533-540. doi: 10.1093/pm/pnx021.
3
CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016.美国 2016 年慢性疼痛阿片类药物处方指南。
MMWR Recomm Rep. 2016 Mar 18;65(1):1-49. doi: 10.15585/mmwr.rr6501e1.
4
The Pain and Opioids IN Treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain.疼痛与阿片类药物治疗研究：使用阿片类药物管理慢性非癌性疼痛的队列特征
Pain. 2015 Feb;156(2):231-242. doi: 10.1097/01.j.pain.0000460303.63948.8e.
Zotero 插件